Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 15, 2020

SELL
$5.71 - $15.85 $228,400 - $634,000
-40,000 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$9.6 - $17.75 $480,000 - $887,500
-50,000 Reduced 55.56%
40,000 $611,000
Q3 2019

Nov 14, 2019

BUY
$12.16 - $21.0 $608,000 - $1.05 Million
50,000 Added 125.0%
90,000 $1.1 Million
Q2 2019

Aug 13, 2019

BUY
$9.44 - $19.8 $377,600 - $792,000
40,000 New
40,000 $792,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.